4 days ago
Cambridge, MA, USAIntern
H1B sponsor
Base Salary
$40k - $111k/yr
Responsibilities
- Design and build agent-assisted systems or components for feasibility assessment and exploration of patient phenotypes and clinical profiles in EHR-linked biobanks.
- Reuse and customize AI language models to convert natural-language scientific questions into machine-generated queries evaluated in agentic loops.
- Create guardrails and evaluations to promote and measure the reliability of models and agents.
- Apply the developed tools and technologies to answer patient-data feasibility questions.
Requirements
- Currently enrolled in at least a master's degree program in clinical informatics, epidemiology, computational medicine, biomedical informatics, biostatistics, computer science with a strong interest in biomedical applications, or a related field; PhD students are encouraged to apply.
- Have computational and software engineering fundamentals sufficient to run and tune local LLMs, build local agentic systems, and apply or outline software and agent development practices.
- Demonstrate proficiency in Python and SQL, ideally including database-agnostic querying such as ibis.
- Have experience querying structured EMR/EHR data or demonstrated interest in learning to create patient features, build cohorts, and report summary statistics.
- Preferred qualifications include interests or experience in clinical informatics, clinical machine learning, computational medicine, NLP, LLM research, epidemiology, data engineering, statistical methods, OMOP CDM and medical coding systems, Databricks, R, and tidyverse.
- Demonstrate excellent academic achievement, analytical ability, communication, interpersonal skills, and collaborative effectiveness.
Benefits
- Six-month full-time formal co-op during 2027–2028.
- Cambridge, Massachusetts location with no relocation, travel, or flexible work arrangement required.
- Intern/Co-op fixed-term employee status.
- Day shift schedule.
Categories
About Merck
Merck & Co. is a publicly traded biopharmaceutical company that discovers, manufactures, and sells prescription medicines, vaccines, and animal health products to healthcare systems, physicians, and governments worldwide. Known as MSD outside the U.S. and Canada, it develops products across oncology, vaccines, infectious diseases, and cardiometabolic conditions, including the cancer therapy Keytruda. Founded in 1891 and headquartered in Rahway, New Jersey, it operates global R&D and manufacturing networks and is listed on the NYSE (MRK).